Hoxworth Blood Center welcomes new chief financial officer/executive doctor of business administration
Hoxworth Blood Center, University of Cincinnati, is pleased to announce the appointment of new chief financial officer/executive doctor of business administration (CFO/EDBA), Nick Leibold, MBA.
Leibold comes to Hoxworth after a financial career in highly prestigious investment, financial and pharmaceutical corporations in New York and work as a successful chief financial officer and co-chief executive officer of a pharmaceutical company with employees and operations across 40+ states.
“Mr. Leibold’s expertise will help us support and strengthen the services we provide to patients and donors in the Tri-State,” states Hoxworth director, José Cancelas, MD, PhD. “He brings many attributes to the senior leadership of Hoxworth and will play a key role in our strategic efforts going forward.”
Leibold, a Cincinnati native, earned his B.S. in Finance from Miami University and his MBA from the Stern School of Business of New York University.
Hoxworth Blood Center welcomed Leibold’s arrival on March 27, 2023.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.